The purpose of clinical trials is research.
Clinical trials are studies in which people volunteer either as healthy participants or those that are suffering from a particular illness to help determine whether a new treatment is safe and effective for use in the general population.
Sometimes the studies include use of a particular test agent or treatment to check its effectiveness on a disease or disease process and sometimes a study can be as simple as gathering demographic information on certain areas of the population to determine trends in the healthcare needs of the general population.
We were selected as DRCR Site of the Month again in June.
In the last quarter, we are in the Top 10 (of about 400 sites) for DRCR.
In July, we were tied for the top site in the country for the TELESCOPE trial.
And, we just received approval as a full site for the Annexon-sponsored ARCHER Trial for dry AMD.
More research opportunities may be available. If you or someone you love has been diagnosed with dry AMD, please make an appointment with one of our physicians to examine whether you may be a candidate.
August 20, 2021
Haile Robertson, Assistant Study Coordinator
Tim Holle, Photography
Phase 4 Elevatum Trial - News Phase 4 Elevatum Trial Will Observe Faricimab In Underrepresented DME Populations.
Matthew Cunningham, MD, FASRS explains the need for greater inclusion of impacted races and ethnicities in ophthalmic clinical trials. A new phase 4 clinical trial from Genentech seeks to interpret the efficacy of its newest approved ophthalmic drug, faricimab (Vabysmo) for diabetic macular edema (DME) in patients from underrepresented populations.
The Elevatum trial is enrolling Black, African American, Hispanic, Latin American and Indigenous patients with the leading cause of blindness to assess the population-based clinical efficacy and safety of intravitreal bispecific antibody Ang-2 and VEGF-A inhibitor faricimab, shortly following the drug’s approval for DME and neovascular age-related macular degeneration (nAMD) this January. Click for more information and to see Dr. Cunningham's presentation.
Recognized for his vision in growing the Florida Retina Institute clinical research department.
Karen D. Yesensky, COT
When using a drug that is being tested for its safety and ability to help with certain diseases, there are five steps, or phases, that every clinical trial must go through in order to become FDA approved for use.
Each phase is designed to answer a separate research question.
Participating in a clinical trial is always voluntary. There is no coercion used when offering a trial to a patient, and you can leave any clinical trial at any time for any reason.
Most clinical trials are sponsored by the National Institutes of Health — a federally funded organization. Other trials are sponsored by pharmaceutical and biotech companies that develop the drug or treatment.
If you would like to see a list of all clinical trials available, please click here and go to Clinicaltrials.gov, a resource provided by the U.S. National Library of Medicine. ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. The website provides current information about clinical research studies to patients, their families and caregivers, health care professionals, and the public. Each study record includes a summary of the study protocol, including the purpose, recruitment status, and eligibility criteria. Study locations and specific contact information are listed to assist with enrollment.
For more information about clinical trials or if you should have any questions, please feel free to contact us.